According to the Boston-based biopharmaceutical company, the total charges for the workforce reduction will be approximately $130,000. This action follows the recent interim clinical results in which the
Following approval in Denmark in 2005, Massachusetts-based Indevus filed for Mutual Recognition Procedure (MRP) in the UK, Ireland, Germany, Spain and Italy. The Committee for Medicinal Products for
The decision means that Merck & Co.’s rival product Gardasil, which is already available in the US, will remain unchallenged until 2008, when GSK expects to launch Cervarix.
Critical Therapeutics, together with its co-promotion partner Dey, said that it expects to begin marketing Zyflo CR in the US in the fall of 2007. Zyflo CR and
Patient enrollment is currently projected to begin in the third quarter of 2007, and the study protocol provides for an interim analysis, which the company expects to occur
The study, led by researchers at the Ohio State University Comprehensive Cancer Center, shows that the inherited mutation greatly reduces the gene’s protective activity. Furthermore, a second kind
In its final appraisal determination, NICE concluded that Champix (varenicline) was “superior to NRT (nicotine replacement therapy) and bupropion in achieving continuous abstinence” and that its use in
Novacea is currently conducting a large international phase III trial evaluating Asentar in 900 patients with androgen-independent prostate cancer (AIPC). Asentar is a novel, proprietary, high-dose oral formulation
According to Mylan, the 40mg strength of fluoxetine capsules, the generic name for Prozac, had US sales of approximately $118 million for the 12 months ending March 31,
Under the terms of the agreement, CeNeRx has been granted an exclusive worldwide license to develop, manufacture and commercialize the PharmaNess cannabinoid portfolio, currently including over a dozen
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.